Emily Hinchcliff

机构：Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University · ORCID：0000-0002-0593-6321

发表论文 127 篇 · 总被引 2017 次 · h-index 19

代表论文

• Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial (2025 · Nature Medicine · 被引 69)
• PPP2R1A mutations portend improved survival after cancer immunotherapy (2025 · Nature · 被引 30)
• Fit4Surgery: A pilot randomized controlled trial to assess the feasibility of prehabilitation prior to debulking surgery for ovarian cancer (2025 · Gynecologic Oncology · 被引 5)
• Same-day discharge after minimally invasive hysterectomy for endometrial cancer and endometrial intraepithelial neoplasia in patients with morbid obesity: Safety and potential barriers (2024 · International Journal of Gynecological Cancer · 被引 2)
• Pembrolizumab-associated hemophagocytic lymphohistiocytosis in recurrent metastatic squamous cell carcinoma of the ovary arising in a teratoma (2026 · Gynecologic Oncology Reports · 被引 1)
• Advances in Cervical Cancer (2025 · Hematology/Oncology Clinics of North America · 被引 1)